Skip to main content
European Commission logo
English English
CORDIS - EU research results
CORDIS
CORDIS Web 30th anniversary CORDIS Web 30th anniversary

Laser-induced vapour nanobubbles for intracellular delivery of nanomaterials and treatment of biofilm infections

Periodic Reporting for period 4 - NANOBUBBLE (Laser-induced vapour nanobubbles for intracellular delivery of nanomaterials and treatment of biofilm infections)

Reporting period: 2020-03-01 to 2021-02-28

Lasers have found widespread application in medicine, such as for photothermal therapy. Gold nanoparticles (AuNPs), are often used as enhancers of the photothermal effect since they can efficiently absorb laser light and convert it into thermal energy. When absorbing intense nano- or picosecond laser pulses, AuNPs can become extremely hot and water vapor nanobubbles (VNBs) can emerge around these particles in tissue. A VNB will expand up to several hundred nm until the thermal energy from the AuNP is consumed, after which the bubble violently collapses, causing mechanical damage to neighbouring structures. In this project the aim is to make use of the disruptive mechanical force of VNBs to enable highly controlled and efficient delivery of macromolecules and nanoparticles in cells and biofilms. First, optical set-ups and microfluidics devices will be developed for high-throughput treatment of cells and biofilms. Second, VNBs will be used to achieve efficient cytosolic delivery of functional macromolecules in mammalian cells by cell membrane perforation or by inducing endosomal escape of endocytosed nanomedicine formulations that are functionalized with AuNPs. These concepts will be applied to tumorigenesis research, generation of induced pluripotent stem cells and modulation of effector T-cells for adoptive T-cell anti-cancer therapy. Third, contrast nanoparticles for cell imaging will be delivered into the cytosol of mammalian cells through VNB induced cell membrane perforation. This will enable more reliable in vivo imaging of labelled cells, labelling of subcellular structures for time-lapse microscopy and intracellular biosensing. Finally, the disruptive force of laser-induced VNBs will be used to release cells from their protective environment in biofilms and improve delivery of antimicrobial agents to deep cell layers for improved eradication of biofilms. This concept will be applied to biofilm infections in dental root canals and chronic wounds.
- Ultra-fast photoporation device developed.
- Concept of spatial-selective photoporation was demonstrated.
- Microfluidic chips for photoporation of suspension cells under development.
- Demonstrated that photoporation works on many different cell types, including primary cells, and for many different cargos (siRNA, fluorescent labels etc). Currently experimental conditions are being optimized for intracellular delivery of large macromulecules including mRNA and pDNA.
- VNB photoporation for light-triggered endosomal release of nanocarriers successful for siRNA, but still under development for mRNA and pDNA.
- Successfully photoporated hard-to-transfect primary T-cells with siRNA, mRNA and CRISPR/CAS9 ribonucleoproteins.
- Advantages of delivering contrast agents into cells with photoporation has been demonstrated.
- Application of photoporation to the treatment of biofilm infections successfully developed.
In the initial phase of the NANOBUBBLE project we have demonstrated that photoporation is a widely applicable enabling technology to deliver a broad range of cargo's into live cells. Delivering biofunctional molecules and labels into cells is a fundamental requirement in life science research in which cells and tissues are involved. As such the photoporation technology is expected to have a wide impact on these fields that range from fundamental cell biology, over intracellular drug delivery, to drug screening and tissue engineering.
Individual cells can be transfected in high-throughput